4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Persistent Corneal Epithelial Defect: new trials by email Literature Review of Persistent Corneal Epithelial Defect trials Research Report on Persistent Corneal Epithelial Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S) - Persistent Corneal Epithelial Defect | Phase 2 | Completed | Kiora Pharmaceuticals, Inc. | 10 | 2022-07-01 | 2024-04-03 |
| ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects ST266 - Persistent Corneal Epithelial Defect | Phase 2 | Completed | Noveome Biotherapeutics, formerly Stemnion | 13 | 2019-06-10 | 2021-08-18 |
| Autologous Platelet Lysate in Corneal Epithelial Defects Platelet Lysate - Persistent Corneal Epithelial Defect | Phase 1 / Phase 2 | Completed | Hanan Jafar | 10 | 2017-02-16 | 2021-03-03 |
| Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect DE-105 ophthalmic solution, Placebo ophthalmic solution - Persistent Corneal Epithelial Defect | Phase 2 | Completed | Santen Pharmaceutical Co., Ltd. | 45 | 2009-09-01 | 2012-11-22 |
Hanan Jafar (1) · Kiora Pharmaceuticals, Inc. (1) · Noveome Biotherapeutics, formerly Stemnion (1) · Santen Pharmaceutical Co., Ltd. (1)
Japan (1) · Jordan (1) · Mexico (1) · United States (1)
Abdallah Awidi, MD (1) · Enrique Graue, M.D. (1)